NIH-funded research R15 grant

Exploring new ring-shaped molecules to influence protein interactions

Official title: Disrupting Protein-Protein Interactions with Self-Assembling Macrocycles

Funded at Texas Christian University · NIH-10796097 · Data updated 2026-11-12

This study is exploring new ring-shaped molecules that could help create better drugs for diseases like breast cancer by changing how proteins interact with each other.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionTexas Christian University
NIH-funded
Lab location1 site (Fort Worth, United States)
Project startSeptember 15, 2019
Project endAugust 31, 2026
Funding year2023
Award (this year)$336,625
NIH project number2R15GM135900-02
Project IDNIH-10796097 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with breast cancer who may benefit from new therapeutic strategies targeting protein interactions.

Less likely to help

Patients with conditions unrelated to protein interactions or those who are not diagnosed with cancer may not receive benefits from this research.

What this research studies

This research investigates a novel class of ring-shaped molecules, known as macrocycles, which have the potential to modulate interactions between proteins. By utilizing dynamic covalent chemistry, the researchers aim to create these macrocyclic compounds in a way that allows for precise control over their structure and function. This could lead to the development of new drugs that target specific protein interactions, which is crucial for treating various diseases, including breast cancer. The project focuses on understanding how changes in the molecular structure can affect the efficacy of these compounds in drug design.

Why it matters

Potential benefit: If successful, this research could lead to the development of innovative therapies for diseases like breast cancer by targeting protein interactions more effectively.

How similar studies have gone: While the approach of using macrocyclic molecules to influence protein interactions is relatively novel, there is growing interest and investment in this area, indicating potential for success based on preliminary findings in related research.

Where this research is happening

  • Texas Christian University
    Fort Worth, United States
    Active

Researchers

  • Principal investigator: Simanek, Eric E — Texas Christian University
  • Study coordinator: Simanek, Eric E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.